Video
8 Mar 2019
Zim Laboratories Limited at CPHI Worldwide 2018
Content provided by our supplier
Zim Laboratories Ltd.
-
IN -
2015On CPHI since
Other Content from Zim Laboratories Ltd. (1)
-
News ZIM Announces Submission of Marketing Authorization Application for 'Rizatriptan' orally dissolving film in Europe
ZIM Laboratories Limited (ZIM) announced that it has filed the regulatory dossier for approval of Rizatriptan orally dissolving film in Europe.Rizatriptan orally dissolving film is a product developed using our Thinoral® technology which yields instantly wettable, rapidly dissolving, and stable films. The product is used in the treatment of migraine which is invariably associated with symptoms like nausea and vomiting.The fast dissolving features provides fast onset of action.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance